CLClinicLens

Unclassified

FDA Authorizes 20 Nicotine Pouches to Be Marketed With Modified Risk Claim | ClinicLens

The US Food and Drug Administration (FDA) authorized 20 nicotine pouches to be marketed as modified risk tobacco products.

Medical Literature · Updated

← Back to articles
This standalone article is served from the ClinicLens content archive.

If the embedded page does not load in your browser, open it directly.